Back to Search
JORDAN SACK, MD, MPH
MD, MPH
Hepatology Physician
NPI: 1669883245IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hepatology PhysicianPrimary
Internal Medicine — Hepatology
Code: 207RI0008X
287611(MA)
Gastroenterology Physician
Internal Medicine — Gastroenterology
Code: 207RG0100X
287611(MA)
Transplant Hepatology Physician
Internal Medicine — Transplant Hepatology
Code: 207RT0003X
287611(MA)
CMS Specialties
PrimaryGASTROENTEROLOGY
Education
WARREN ALPERT MEDICAL SCHOOL OF BROWN UNIVERSITY
Class of 2014
Research & Publications (20)
What's your assessment? Primary melanoma arising in association with a blue nevus.
PMID 18549126·Dermatol Nurs·2008
5-case
Structural basis for the high-affinity binding of pyrrolotriazine inhibitors of p38 MAP kinase.
PMID 18566506·Acta Crystallogr D Biol Crystallogr·2008
8-other
A gastropod toxin selectively slows early transitions in the Shaker K channel's activation pathway.
PMID 15148327·J Gen Physiol·2004
7-preclinical
Postpartum maternal hyperthyrotropinemia in an area in which iodine supplementation is required.
PMID 14611705·Thyroid·2003
3-trial
Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone.
PMID 11320241·Proc Natl Acad Sci U S A·2001
7-preclinical
Clinical and genetic heterogeneity of congenital adrenal hypoplasia due to NR0B1 gene mutations.
PMID 19508677·Clin Endocrinol (Oxf)·2010
8-other
Management and outcomes of patients undergoing surgery for traumatic cervical fracture-subluxation associated with an asymptomatic vertebral artery injury.
PMID 19342928·J Spinal Disord Tech·2009
8-other
N-aryl-oxazolidin-2-imine muscle selective androgen receptor modulators enhance potency through pharmacophore reorientation.
PMID 19351168·J Med Chem·2009
7-preclinical
Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily.
PMID 19260711·J Med Chem·2009
7-preclinical
How to validate a heteromeric ion channel drug target: assessing proper expression of concatenated subunits.
PMID 18411330·J Gen Physiol·2008
7-preclinical
Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitors.
PMID 18479916·Bioorg Med Chem Lett·2008
7-preclinical
Discovery of pyrrolopyridine-pyridone based inhibitors of Met kinase: synthesis, X-ray crystallographic analysis, and biological activities.
PMID 18690676·J Med Chem·2008
7-preclinical
Identification of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of Met kinase.
PMID 18289854·Bioorg Med Chem Lett·2008
7-preclinical
Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38 alpha MAP kinase inhibitors.
PMID 18364256·Bioorg Med Chem Lett·2008
7-preclinical
Early blood thyroxine concentration and necrotizing enterocolitis in premature infants.
PMID 18298778·Acta Paediatr·2008
8-other
The discovery of (R)-2-(sec-butylamino)-N-(2-methyl-5-(methylcarbamoyl)phenyl) thiazole-5-carboxamide (BMS-640994)-A potent and efficacious p38alpha MAP kinase inhibitor.
PMID 18313298·Bioorg Med Chem Lett·2008
7-preclinical
Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitors.
PMID 18359226·Bioorg Med Chem Lett·2008
8-other
Benzothiazole based inhibitors of p38alpha MAP kinase.
PMID 18296051·Bioorg Med Chem Lett·2008
7-preclinical
Removable colonic stenting: time to expand the indications?
PMID 18926180·Gastrointest Endosc·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 1153 Centre Street, Suite 4B
Boston, MA 02130 - Phone
- (617) 983-7848
Quick Facts
- NPI
- 1669883245
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 3
- Years in Practice
- 12
- Publications
- 20
Are you this provider?
Claim Your Profile